
First ask for trust, then seal the files: why vaccine injury needs transparency
During the corona period, citizens were asked to quickly give confidence: in vaccines, regulators, pharmaceutical companies and political decision-making. Years later, the second half of that trust appears to be much slower. Anyone who wants to see the underlying files, raw reports, injury claims or trial documents will encounter privacy rules, business confidentiality, anonymized datasets, long waiting times and sometimes lawsuits in several countries. That does not prove a global cover-up, but it does make the question of transparency urgent.

























